Transgene Immunogenicity

Transgene Immunogenicity is the propensity of a transgene-encoded protein to elicit an adaptive immune response against its expressed product following gene therapy, distinguished from other sources of immunogenicity by its origin in exogenously delivered genetic material rather than host antigens or vector components.

40

Publications

3.6K

Citations

293

Authors

105

Institutions

Publications per year

2017–2026

12

Authors

293

  1. QS
    Qin Su

    University of Massachusetts Chan Medical School, United States

    2 publications · 415 citations

    2

    h-index

  2. VR
    Valder R. Arruda

    Children's Hospital of Philadelphia, United States

    2 publications · 296 citations

    2

    h-index

  3. JF
    J. Fraser Wright

    Children's Hospital of Philadelphia, United States

    2 publications · 296 citations

    2

    h-index

  4. CO
    Carol O. Tacket

    University of Maryland, Baltimore, United States

    2 publications · 784 citations

    2

    h-index

  5. JM
    John M. Howell

    The University of Western Australia, Australia

    1 publications · 105 citations

    1

    h-index

1–5 of 293

Venues

  1. Human Gene Therapy

    4 publications · 170 citations

    4

    h-index

  2. Molecular Therapy

    3 publications · 265 citations

    3

    h-index

  3. Gene Therapy

    3 publications · 157 citations

    3

    h-index

  4. 2

    h-index

  5. PubMed

    Repository · 2 publications · 78 citations

    2

    h-index

1–5